These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7862640)

  • 1. Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformation.
    Kiyokawa N; Yan DH; Brown ME; Hung MC
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1092-6. PubMed ID: 7862640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cdc2-mediated phosphorylation in the cell cycle-dependent regulation of p185neu.
    Kiyokawa N; Karunagaran D; Lee EK; Xie Y; Yan DH; Hung MC
    Oncogene; 1997 Nov; 15(22):2633-41. PubMed ID: 9400990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
    Zhang HT; O'Rourke DM; Zhao H; Murali R; Mikami Y; Davis JG; Greene MI; Qian X
    Oncogene; 1998 Jun; 16(22):2835-42. PubMed ID: 9671404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu.
    Xie Y; Li K; Hung MC
    Oncogene; 1995 Jun; 10(12):2409-13. PubMed ID: 7784091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties.
    Zhang L; Lau YK; Xi L; Hong RL; Kim DS; Chen CF; Hortobagyi GN; Chang C; Hung MC
    Oncogene; 1998 Jun; 16(22):2855-63. PubMed ID: 9671406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the neu oncogene product in cell transformation and normal development.
    Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
    Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.
    Qian X; O'Rourke DM; Zhao H; Greene MI
    Oncogene; 1996 Nov; 13(10):2149-57. PubMed ID: 8950982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage of tyrosine kinase activity with transforming ability of the p185neu oncoprotein.
    Weiner DB; Kokai Y; Wada T; Cohen JA; Williams WV; Greene MI
    Oncogene; 1989 Oct; 4(10):1175-83. PubMed ID: 2571965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of p185neu sequences required for monoclonal antibody- or ligand-mediated receptor signal attenuation.
    Qian X; O'Rourke DM; Drebin J; Zhao H; Wang Q; Greene MI
    DNA Cell Biol; 1997 Dec; 16(12):1395-405. PubMed ID: 9428788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic activation of the PDGF beta receptor by the transmembrane domain of p185neu*.
    Petti LM; Irusta PM; DiMaio D
    Oncogene; 1998 Feb; 16(7):843-51. PubMed ID: 9484775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin.
    Zhang L; Chang CJ; Bacus SS; Hung MC
    Cancer Res; 1995 Sep; 55(17):3890-6. PubMed ID: 7543819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer.
    Lai GH; Zhang Z; Shen XN; Ward DJ; Dewitt JL; Holt SE; Rozich RA; Hixson DC; Sirica AE
    Gastroenterology; 2005 Dec; 129(6):2047-57. PubMed ID: 16344070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu.
    Hong RL; Spohn WH; Hung MC
    Clin Cancer Res; 1999 Jul; 5(7):1884-91. PubMed ID: 10430096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
    Tarakhovsky A; Zaichuk T; Prassolov V; Butenko ZA
    Oncogene; 1991 Dec; 6(12):2187-96. PubMed ID: 1685016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active.
    Yarden Y
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2569-73. PubMed ID: 1969636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2.
    Wildenhain Y; Pawson T; Blackstein ME; Andrulis IL
    Oncogene; 1990 Jun; 5(6):879-83. PubMed ID: 1694290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of oncogenic and cellular p185 by serine/threonine kinases.
    Dobashi K; Weiner DB; Greene MI
    DNA; 1989 Dec; 8(10):723-32. PubMed ID: 2575488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermolecular association and trans-phosphorylation of different neu-kinase forms permit SH2-dependent signaling and oncogenic transformation.
    Qian X; Dougall WC; Fei Z; Greene MI
    Oncogene; 1995 Jan; 10(1):211-9. PubMed ID: 7824275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
    Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
    Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract.
    Cohen JA; Weiner DB; More KF; Kokai Y; Williams WV; Maguire HC; LiVolsi VA; Greene MI
    Oncogene; 1989 Jan; 4(1):81-8. PubMed ID: 2563577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.